Bank Of New York Mellon Corp Ovid Therapeutics Inc. Transaction History

Bank Of New York Mellon Corp

$521 Trillion
Q1 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.43 - $1.86 $118,710 - $154,406	83,014 New	83,014 $154,000
Q3 2022 Nov 14, 2022	BUY	$1.85 - $2.26 $8,511 - $10,398	4,601 Added 2.1%	223,488 $411,000
Q2 2022 Aug 15, 2022	SELL	$1.69 - $3.31 $20,484 - $40,120	-12,121 Reduced 5.25%	218,887 $470,000
Q1 2022 May 11, 2022	SELL	$2.65 - $3.49 $56,087 - $73,865	-21,165 Reduced 8.39%	231,008 $726,000
Q4 2021 Feb 11, 2022	BUY	$3.13 - $3.73 $421,526 - $502,330	134,673 Added 114.62%	252,173 $810,000

Q3 2021 Nov 12, 2021	BUY	$3.31 - $4.04 $84,911 - $103,638	25,653 Added 27.93%	117,500 $396,000
Q2 2021 Aug 11, 2021	SELL	$3.3 - $4.49 $195,303 - $265,731	-59,183 Reduced 39.19%	91,847 $359,000
Q1 2021 May 13, 2021	BUY	$2.42 - $4.47 $38,156 - $70,478	15,767 Added 11.66%	151,030 $607,000
Q4 2020 Feb 09, 2021	BUY	$2.28 - $6.84 $31,254 - $93,762	13,708 Added 11.28%	135,263 $312,000
Q3 2020 Nov 12, 2020	SELL	$5.39 - $8.24 $5,487 - $8,388	-1,018 Reduced 0.83%	121,555 $697,000
Q2 2020 Aug 12, 2020	BUY	$2.67 - $7.91 $269,963 - $799,780	101,110 Added 471.09%	122,573 $903,000
Q1 2020 May 06, 2020	BUY	$2.03 - $4.35 $43,569 - $93,364	21,463 New	21,463 $63,000
Q2 2019 Aug 12, 2019	SELL	$1.59 - $2.14 $55,093 - $74,151	-34,650 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$1.77 - $3.56 $205 - $412	-116 Reduced 0.33%	34,650 $61,000
Q4 2018 Feb 11, 2019	BUY	$2.42 - $6.6 $84 - $231	35 Added 0.1%	34,766 $84,000
Q3 2018 Nov 09, 2018	BUY	$5.6 - $11.0 $17,001 - $33,396	3,036 Added 9.58%	34,731 $0
Q2 2018 Aug 06, 2018	BUY	$6.16 - $10.14 $38,851 - $63,952	6,307 Added 24.84%	31,695 $247,000
Q1 2018 May 15, 2018	BUY	$6.53 - $9.82 $77,635 - $116,749	11,889 Added 88.07%	25,388 $180,000
Q4 2017 Feb 09, 2018	BUY	$6.12 - $12.31 $82,613 - $166,172	13,499	13,499 $133,000

Others Institutions Holding OVID

# of Institutions

Shares Held

43.2M

Call Options Held

5.9K

Put Options Held

300

Eco R1 Capital, LLC San Francisco, CA

6.12M
Shares

$4.59 Million
0.53% of portfolio
Rubric Capital Management LP New York, NY

5.32M
Shares

$3.99 Million
0.55% of portfolio
Black Rock Inc. New York, NY

4.2M
Shares

$3.15 Million
0.0% of portfolio
Bvf Inc San Francisco, CA

3.85M
Shares

$2.89 Million
0.35% of portfolio
Madison Avenue Partners, LP New York, NY

3.65M
Shares

$2.74 Million
2.22% of portfolio

View Full List

About Ovid Therapeutics Inc.

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $52.8M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

More about OVID

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account